Controlling infection puts a heavy burden on hospitals in both financial and bed management aspects. Due to financial pressure and healthcare quality requirements, bed management is an essential part of daily life in healthcare facilities. An effective way to control the spread of pathogens in hospitals needs a technology that supports bed management and relieve the coordination of admissions.
It has been published that infection control interventions reduce costs and improve outcomes in intensive care. It is also proven that patients with delirium in the ICU has significantly higher mortality. Even in one-bed hospital rooms (used for isolating infections), delirium occurs in over 80% of critically ill patients and associated with increased length of stay and increased mortality.
This technology provides a mobile ICU which is an easy to install personalized ward. This is the unique device, which is capable of isolating patient from infections and non-stop healthcare related activities in conjunction with delirium. This can be operated by staff of the intensive care (doctors and nurses) in the hospital.
The unique nature of the technology comes from the fusion of 3 factors: IP legal protection/ unique know-how/ public domain making this solution difficult for others to replicate.
For adults treated in the Intensive Care Unit:
For health investment and insurance sector
This medical equipment is to accommodate intensive care patients with their bed that uses numerous physical factors with options for (i) pain and anxiety management in obstetrics delivery rooms, (ii) individualized patient feeding, (iii) external fever control, (iv) addition of music therapy and (v) air medical transport with varying atmospheric pressure.
The technology partner is open to conduct R&D collaboration through a joint venture.
280 thousand critical care beds are maintained in Europe, North America and South- East Asia for their population of 2.553 million. Stopping the spread of infections and allowing faster patient recovery will give approx. USD65k savings on ICU beds annually.
The value propositions of this unique medical device are deployability, increased recovery support and improved patient safety. The alternative solution (i) is not portable; (ii) does not reduce patient’s delirium, (iii) cannot provide aseptic germ-free air; (iv) cannot adjust air humidity, pressure and oxygen content; and (v) does not cover options for further individualization.